Skip to main content

Navigation group

Type at least 3 characters
26,729 articles

Articles

Brief Research Report

Accepted on 28 Mar 2024

Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M Osimertinib-and trastuzumab-resistant and ERBB2-expressing non-small cell lung cancer (NSCLC) via the reduction of ERBB2

in Cancer Molecular Targets and Therapeutics

  • Chidiebere U Awah
  • Joo Sun Mun
  • Alooka Paragodaarachchi
  • Baris Boylu
  • Martin Nzegwu
  • Hiroshi Matsui
  • Olorunseun O Ogunwobi
Frontiers in Oncology
doi 10.3389/fonc.2024.1344852